Manufacturer
Gland Pharma Ltd
Contents
Omeprazole
Indication
Eradication of H. pylori associated with peptic ulcer disease, Gastric and duodenal ulcers, Gastro-oesophageal reflux disease, NSAID-associated ulceration, Zollinger-Ellison syndrome.
Instruction
Administer via IV Infusion.
Drug interaction
May decrease plasma concentrations of nelfinavir and atazanavir. Increased risk of hypomagnesaemia with diuretics. May increase plasma concentration of tacrolimus, methotrexate. May decreased absorption of itraconazole, ketoconazole, posaconazole, erlotinib. May decrease metabolism of diazepam, phenytoin, cilostazol. May reduce the antiplatelet activity of clopidogrel. May increase bioavailability of digoxin.
Malaysia
